A-Med Medical Supply Division has been acquired by Byram Healthcare Centers, Inc.
A-Med Health Care (A-Med) has sold its Medical Supplies Division to Byram Healthcare Centers, Inc. (Byram), a wholly owned subsidiary of Mediq NV. The acquisition represents an EBITDA multiple of approximately 7.5x, excluding synergies.
Founded in 1982 and headquartered in Huntington Beach, California, A-Med is one of the leading distributors of incontinence and urology supplies in the California market serving Medicare, Medicaid / Medi-Cal and managed care patients.
Byram operates as a US subsidiary of Mediq NV, an international company delivering medical devices, pharmaceuticals and related care services. Mediq delivers via three channels: direct to people's homes (Direct), to professional customers such as hospitals, nursing homes and GPs (Institutional) and via Mediq Pharmacies. Mediq operates in 15 countries and has its head office in Utrecht, the Netherlands. This acquisition will establish Byram as a leading provider of medical supplies in the Californian home care market.
A-Med Health Care is a specialty pharmacy providing advanced medications, infusions, supplies, and services to patients living with complex conditions. The company provides support for patients suffering from conditions such as Cystic Fibrosis, HIV/AIDS, Multiple Sclerosis, organ transplants and paraplegia. A-Med Health Care, founded in 1982 and with approximately 200 employees, services patients all across the country.
Oaklins' team in Los Angeles acted as the exclusive financial advisor to A-Med in connection with this asset sale. The transaction was facilitated by Oaklins' team in the Netherlands who identified and contacted Mediq on behalf of the American team. This transaction once again highlights our ability to close deals worldwide.
Talk to the deal team
Gary Rabishaw
Oaklins Intrepid
Eduard Bagdasarian
Oaklins Intrepid
Jeremiah Mann
Oaklins Intrepid
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more